SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Frostman who wrote (22653)1/4/2000 9:21:00 AM
From: Bipin Prasad  Read Replies (1) of 23519
 
from briefing.com;
VIVUS Inc (VVUS) 4 1/32: Company's VIVUS International subsidiary announces resolution of all financial obligations relating to the return to VIVUS of marketing and distribution rights for MUSE from AstraZeneca. VVUS expects resolution to result in significantly increased revenues for Q4 of 1999 and the Q1 of 2000.

InSook Prasad
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News